J&J opens the valve on $50M MS partnership with Pipeline
Abbott gets clearance for Libre 3 reader, opening path to Medicare coverage
The end of an era: Regeneron chairman Roy Vagelos to retire after 29-year run
Merck to buy inflammatory disease drugmaker Prometheus for $10.8B
*please scroll down for all the latest news*
